BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30701729)

  • 1. Features of the clinics and treatment of patients with obesity and hypertension (according to the National register of arterial hypertension).
    Oshchepkova EV; Lazareva NV; Chazova IE
    Ter Arkh; 2018 Sep; 90(9):8-14. PubMed ID: 30701729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of duration and treatment of arterial hypertension on health-related quality of life].
    Raskeliene V; Babarskiene MR; Macijauskiene J; Seskevicius A
    Medicina (Kaunas); 2009; 45(5):405-11. PubMed ID: 19535887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
    Sun X; Du T
    BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical-Epidemiological Program of Studying Psychosocial Risk Factors in Cardiological Practice in Patients With Arterial Hypertension and Ischemic Heart Disease: First Results of a Multicenter Study in Russia].
    Pogosova NV; Boytsov SA; Oganov RG; Yufereva YM; Kostyuk GP; Kursakov AA; Ausheva AK; Vygodin VA
    Kardiologiia; 2018 Sep; 58(9):47-58. PubMed ID: 30295199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
    Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
    Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of prevalence of arterial hypertension and other risk factors of development of cardiovascular diseases in female population of Tallin (10 year prospective study)].
    Shipilova T; Pshenichnikov I; Abina E; Karaĭ D; Ripul'k E; Veski K; Pil't K; Meĭgas K; Kaĭk Iu
    Kardiologiia; 2010; 50(11):40-6. PubMed ID: 21526563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
    Briskman I; Bar G; Boaz M; Shargorodsky M
    Int J Psychiatry Med; 2012; 43(4):339-48. PubMed ID: 23094466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension).
    Chazova IE; Lazareva NV; Oshchepkova EV
    Ter Arkh; 2019 Mar; 91(3):4-10. PubMed ID: 31094451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Fernández-SanMartín M; Goday-Arno A
    Clin Exp Hypertens; 2017; 39(5):441-447. PubMed ID: 28590147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and demographic characteristics of various types of arterial hypertension in elderly patients (based on results of Russian scientific-practical program ARGUS].
    Kobalova ZhD; Kotovskaia IuV; Aseeva OA; Vereshchagina GN; Galiavich AS; Drozdetskiĭ SI; Shlyk SV
    Ter Arkh; 2002; 74(2):47-51. PubMed ID: 11899825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of arterial hypertension and type 2 diabetes mellitus with obesity].
    Pinkhasov BB; Seliatitskaia VG; Mitrofanov IM; Anufrienko AV; Dolgova NA
    Klin Med (Mosk); 2014; 92(9):65-9. PubMed ID: 25790715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk and inflammatory markers in patients with hypertension].
    Krzesiński P; Hałas K; Gielerak G; Piotrowicz K; Stańczyk A; Piechota W; Jannasz I; Niedolaz K; Wojdat M; Skrobowski A
    Pol Merkur Lekarski; 2015 Feb; 38(224):70-6. PubMed ID: 25771514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MAURO study: baseline characteristics and compliance with guidelines targets.
    Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C;
    J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of Arterial Hypertension in Russian Federation - Importance of Choice of Criteria of Diagnosis].
    Erina AM; Rotar OP; Solntsev VN; Shalnova SA; Deev AD; Baranova EI; Konradi OA; Boytsov SA; Shlyakhto EV
    Kardiologiia; 2019 Jun; 59(6):5-11. PubMed ID: 31242835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
    Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
    Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.